Accession Number: | 0000899243-22-023502 |
Date: | 2022-06-17 |
Issuer: | ATEA PHARMACEUTICALS, INC. (AVIR) |
Original Submission Date: |
ADAMS JEROME M.
225 FRANKLIN STREET
SUITE 2100
BOSTON, MA 02110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.5 | 2022-06-17 | deemed execution date | A | 61,264 (a) | 2032-06-16 | common stock 61,264 | $6.50 | 61,264 | direct |
ID | footnote |
---|---|
f1 | the option vests and becomes exercisable in twelve (12) equal monthly installments following june 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the reporting person's continued service through each such vesting date. |